A phase II study of eribulin in Japanese patients with heavily pretreated metastatic breast cancer
Author:
Funder
Eisai Inc
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/23/6/1441/399546/mdr444.pdf
Reference28 articles.
1. Treatment options for breast cancer resistant to anthracycline and taxane;Moreno-Aspitia;Mayo Clin Proc,2009
2. Achievements in systemic therapies in the pregenomic era in metastatic breast cancer;Colozza;Oncologist,2007
3. Overview of resistance to systemic therapy in patients with breast cancer;Gonzalez-Angulo;Adv Exp Med Biol,2007
4. Ixabepilone, a new treatment option for metastatic breast cancer;Toppmeyer;Am J Clin Oncol,2010
Cited by 112 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Eribulin versus S-1 as first or second-line chemotherapy to assess health-related quality of life and overall survival in HER2-negative metastatic breast cancer (RESQ study): a non-inferiority, randomised, controlled, open-label, phase 3 trial;eClinicalMedicine;2024-08
2. The therapeutic potential and application of marine alkaloids in treating breast cancer;Frontiers in Marine Science;2024-07-15
3. Best practices for achieving consensus in HER2‐low expression in breast cancer: current perspectives from practising pathologists;Histopathology;2024-07-08
4. Current Status and Future Perspectives of Antibody–Drug Conjugates in Hormone Receptor-Positive Breast Cancer;Cancers;2024-05-08
5. Cost-benefit evaluation of advanced therapy lines in metastatic triple-negative breast cancer in Germany;Cost Effectiveness and Resource Allocation;2024-03-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3